About Nipd genetics
NIPD Genetics: Revolutionizing Genetic Testing
NIPD Genetics is a biotechnology company that specializes in the development of genetic tests for the accurate detection and prognosis of genetic disorders. The company was founded in 2010 by Dr. Philippos Patsalis, a renowned scientist and pioneer in non-invasive prenatal testing (NIPT). Since then, NIPD Genetics has been at the forefront of innovation in the field of genetics, providing cutting-edge solutions to healthcare professionals and patients worldwide.
The mission of NIPD Genetics is to improve human health by providing accurate, reliable, and affordable genetic testing services. The company's core values are excellence, innovation, integrity, teamwork, and customer satisfaction. These values guide every aspect of their operations from research and development to customer support.
NIPD Genetics offers a wide range of genetic tests for various applications such as prenatal diagnosis, cancer diagnosis/prognosis/monitoring/treatment selection/therapy response monitoring/minimal residual disease detection), inherited diseases (including rare diseases), pharmacogenomics (drug metabolism/genetic predisposition to adverse drug reactions), forensic genetics (DNA profiling) etc.
One of the most significant breakthroughs made by NIPD Genetics is their non-invasive prenatal test (NIPT) called Veracity™. This test uses advanced technology to detect fetal DNA fragments in maternal blood samples with high accuracy (>99%) without any risk or discomfort for mother or fetus. Veracity™ can detect chromosomal abnormalities such as Down syndrome with high sensitivity (>99%) and specificity (>99%), making it one of the most reliable NIPTs available on the market today.
Another innovative product developed by NIPD Genetics is their Hereditary Cancer Panel Test which detects mutations associated with hereditary cancers including breast cancer genes BRCA1/2 among others). This test provides valuable information about an individual's risk for developing certain types of cancer so that appropriate preventive measures can be taken.
NIPD Genetics also offers a range of other genetic tests such as carrier screening, pre-implantation genetic testing (PGT), and pharmacogenomics testing. These tests are designed to help individuals make informed decisions about their health and wellbeing.
The team at NIPD Genetics is made up of highly skilled scientists, researchers, and healthcare professionals who are dedicated to advancing the field of genetics. They work tirelessly to develop new technologies and improve existing ones so that patients can receive the best possible care.
In addition to their commitment to innovation, NIPD Genetics is also committed to ethical practices in all aspects of their operations. The company adheres strictly to international guidelines for research ethics and patient confidentiality. They also ensure that all their products meet regulatory requirements in different countries where they operate.
NIPD Genetics has received numerous awards for its innovative products and services. In 2019, the company was awarded the prestigious Frost & Sullivan European Non-Invasive Prenatal Testing Technology Innovation Award for its Veracity™ NIPT test. This award recognizes companies that have demonstrated excellence in developing breakthrough technologies that have a significant impact on human health.
In conclusion, NIPD Genetics is an innovative biotechnology company that is revolutionizing genetic testing with its cutting-edge solutions for accurate detection and prognosis of genetic disorders. Their commitment to excellence, innovation, integrity, teamwork, customer satisfaction makes them stand out from other companies in this field. With a team of highly skilled professionals dedicated to advancing the field of genetics while adhering strictly ethical practices in all aspects of their operations; it's no wonder why they've received numerous awards over time!